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The ultimate goal of our research is the regulation of cellular functions by designed peptides and proteins. Current 
research subjects include (1) development of novel intracellular delivery systems aiming at elucidation and control of 
cellular functions using designed membrane permeable peptide vectors, (2) elucidation of the DNA binding and 
recognition modes of C2H2-type zinc finger proteins and design of artificial transcription factors with various DNA 
binding specificities, and (3) design of stimulation-responsible 
artificial peptides and proteins.
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Creation of Artificial Epidermal Growth 
Factor Receptor Activated by Coiled-Coil 
Peptides
Epidermal growth factor receptor (EGFR) regulates 
various signaling pathways to induce cellular functions 
(e.g. proliferation, survival). If activation of this receptor 
could be controlled on demand, the techniques contribute 
to a lot of valuable aspects of cellular regulations. However, 
because overexpression and overactivation of the EGFR 
lead to cancer-like modality, the control is difficult using 
intact receptor and ligands. From this point of view, our 
research objectives are to create artificial EGFR on cell 
membranes, which can be specifically activated with arti-
ficial ligands.
Coiled-coil has been used in numerous applications 
such as affinity purification, miniaturized antibodies, and 
receptor imaging. Using advantage of the coiled-coil 
peculiarities , we designed artificial EGFR, of which the 
receptor dimerization can be controlled by coiled-coil 
interactions . Growth factor binding to the extracellular 
region of EGFR promotes dimerization of the receptor and 
increases the tyrosine kinase activity of its intracellular 
domain. To create artificial EGFR and ligands, coiled-coil 
peptides (E3 and K4) were used. We designed surface-
exposed tag sequence E3 fused EGFR (E3-EGFR) lacking 
domains I~III and a portion of domain IV, which partici-
pate in dimerization of the EGFR after binding of natural 
ligand (e.g. EGF) to the receptor. To dimerize the E3-
EGFR, we synthesized conjugates of two K4 peptides 
(K4-conjugates), and the linker lengths (~10 angstrom) 
mimic distance during dimerization of the EGFR (Figure 1).
To test receptor activation, E3-EGFR expressed CHO 
cells were treated with the K4-conjugates, and this was 
followed by western blot assay for detection of receptor 
phosphorylation. Treatment of the cells with the K4-
conjugates increased level of the phosphorylation in ~5 
min, and enhanced lamellipodia formations and cell 
migrations were observed. This model-receptor system 
should be applicable to design of various receptors and 
other membrane-associated proteins to attain control of 
cellular functions.
CXCR4 is a Receptor Stimulating the Cellular 
Uptake of Arginine-rich Cell-penetrating 
Peptides: the Relevance to Macropinocytosis 
and HIV Infection
The CXCR4 chemokine receptor is a co-receptor of 
HIV-1 infection in host cells. It has been reported that 
ligand binding to CXCR4 leads to its internalization via 
clathrin-dependent endocytosis. Here, through the photo-
cross-linking study to identify receptors involved in 
internalization of oligoarginine cell-penetrating peptides 
(CPPs), we found that CXCR4 serves as a receptor that 
stimulates internalization of the arginine 12-mer peptide 
(R12), in which actin-driven fluid-phase endocytosis 
(macropinocytosis) plays an important role in cellular 
uptake . Interestingly, CXCR4 was responsible for the 
uptake of R12 (Figure 2), but there was no significant 
effect for the uptake of the arginine 8-mer (R8) or the 
HIV-1 TAT derived CPP. We also found that stimulating 
CXCR4 with its intrinsic ligands, stromal cell-derived 
factor 1α (SDF-1α) and HIV-1 envelope glycoprotein 120 
(gp120), induced macropinocytosis. R12 had activity to 
prevent viral infection for HIV-1IIIB, a subtype of HIV-1 
that uses CXCR4 as a co-receptor for entry into susceptible 
cells. On the other hand, the addition of macropinocytosis 
inhibitor, dimethylamiloride (DMA), resulted in enhance-
ment of viral infection. Thus, the present study showed 
that CXCR4 triggers macropinocytosis, which may have 
implications for the cellular uptake of oligoarginine CPPs 
and internalization of HIV.
Figure 1. Concept of artificial EGFR activated by a helix peptide ligand 
via a coiled-coil formation.
Figure 2. Down-regulation of CXCR4 led to diminished cellular uptake 
of R12-alexa. HeLa cells were transfected with 10 nM CXCR4-targeted 
siRNA for 24 h followed by treatment with 10 µM R12-alexa for 30 min 
at 37°C. Cellular internalization of R12-alexa was analyzed by confocal 
microscopy.
